Nota di contenuto |
Prescription pain reliever abuse: agencies have begun coordinating education efforts, but need to assess effectiveness / United States Government Accountability Office -- Prescription drug control: DEA has enhanced efforts to combine diversion, but could better assess and report program results / United States Government Accountability Office -- Statement of Michele M. Leonhart, Administrator, Drug Enforcement Administration. Hearing on "Responding to the prescription drug epidemic: strategies for reducing abuse, misuse, diversion, and fraud -- Statement of John L. Eadie, MPA, Director, Prescription Monitoring Program Center of Excellence, Brandeis University. Hearing on "Enhancing prescription monitoring programs ability to impede the prescription drug abuse epidemic."
|